Literature DB >> 3284076

Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies.

T G Rosano1, M A Pell, B M Freed, M T Dybas, N Lempert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3284076

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Effects of low-dose prednisolone on cyclosporine pharmacokinetics in liver transplant recipients: radioimmunoassay with specific and non-specific monoclonal antibodies.

Authors:  J C Arnold; J G O'Grady; J M Tredger; R Williams
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

3.  Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function.

Authors:  J S Bleck; H J Schlitt; U Christians; R Schottmann; C Thiesemann; S Strohmeyer; K Kohlhaw; K Wonigeit; R Pichlmayr; K F Sewing
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis.

Authors:  Amr el-Husseini; Fathy el-Basuony; Ihab Mahmoud; Ahmed Donia; Nabil Hassan; Nagy Sayed-Ahmad; Mohamed Sobh
Journal:  Pediatr Nephrol       Date:  2004-07-06       Impact factor: 3.714

5.  Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity.

Authors:  U Christians; K Kohlhaw; J Budniak; J S Bleck; R Schottmann; H J Schlitt; V M Almeida; M Deters; K Wonigeit; R Pichlmayr
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Practical aspects in the use of cyclosporin in paediatric nephrology.

Authors:  P F Hoyer; J Brodehl; J H Ehrich; G Offner
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 7.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

8.  Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.

Authors:  E Jacqz-Aigrain; C Montes; P Brun; C Loirat
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 9.  Cyclosporin clinical pharmacokinetics.

Authors:  A Fahr
Journal:  Clin Pharmacokinet       Date:  1993-06       Impact factor: 6.447

10.  Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients.

Authors:  Ida Robertsen; Pål Falck; Arne K Andreassen; Nina K Næss; Niclas Lunder; Hege Christensen; Lars Gullestad; Anders Asberg
Journal:  Transplant Res       Date:  2013-04-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.